GSA CAPITAL PARTNERS LLP - ATHIRA PHARMA INC ownership

ATHIRA PHARMA INC's ticker is ATHA and the CUSIP is 04746L104. A total of 71 filers reported holding ATHIRA PHARMA INC in Q3 2023. The put-call ratio across all filers is 0.03 and the average weighting 0.1%.

Quarter-by-quarter ownership
GSA CAPITAL PARTNERS LLP ownership history of ATHIRA PHARMA INC
ValueSharesWeighting
Q3 2023$600
-41.3%
297,052
-14.3%
0.05%
-50.0%
Q2 2023$1,022
+13.4%
346,431
-3.8%
0.10%
+14.6%
Q1 2023$901
+4.9%
360,242
+32.9%
0.09%
-16.8%
Q4 2022$859
-99.8%
270,989
+59.9%
0.11%
+59.7%
Q3 2022$503,000169,5180.07%
Other shareholders
ATHIRA PHARMA INC shareholders Q3 2023
NameSharesValueWeighting ↓
VR Adviser, LLC 1,691,623$57,938,0008.52%
ACUTA CAPITAL PARTNERS, LLC 393,000$13,460,0003.66%
Logos Global Management LP 947,873$32,465,0002.78%
RTW INVESTMENTS, LP 2,685,779$88,899,0001.49%
Avidity Partners Management LP 1,043,873$35,753,0001.16%
Perceptive Advisors 3,114,805$106,682,0001.14%
Sofinnova Investments, Inc. 509,168$17,439,0001.04%
HighVista Strategies LLC 32,062$1,098,0000.70%
Rock Springs Capital Management LP 860,902$29,486,0000.62%
PFM Health Sciences, LP 470,227$16,105,0000.57%
View complete list of ATHIRA PHARMA INC shareholders